These AML patients displayed frequent TET2 (52%), NPM1 (31%) and FLT3-ITD (26%) mutations and in about 52% of cases displayed cytogenetic abnormalities (complex in 19%, chromosome 3 in 14% and chromosome 5 or 7 in 20% of cases) [389]. Here, NPM1 is linked to acute myeloid leukemia.